 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Teva Pharmaceutical Industries stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:TEVA! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Teva Pharmaceutical Industries stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company’s products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Volume médio
9.78 million shs
MERCADO CAP
$13.79 billion
Bolsa de Valores
NYSE
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NYSE:TEVA
|
Preparações farmacêuticas
|
Médico
|
151,311 shs
|
Below is a quick guide on how to buy NYSE:TEVA stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Teva Pharmaceutical Industries shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Teva Pharmaceutical Industries – Search for “”NYSE:TEVA”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Teva Pharmaceutical Industries stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
17 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Teva Pharmaceutical Industries in the last year. There are currently 3 sell ratings, 10 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Teva Pharmaceutical Industries stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TEVA, but not buy additional shares or sell existing shares.
Wall Street analysts have given Teva Pharmaceutical Industries a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Teva Pharmaceutical Industries wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:TEVA stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Teva Pharmaceutical Industries stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Teva Pharmaceutical Industries stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NYSE:TEVA stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NYSE:TEVA stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:TEVA is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Teva Pharmaceutical Industries stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Teva Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for Teva Pharmaceutical Industries.
Teva Pharmaceutical Industries will be holding an earnings conference call on Wednesday, February 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced its quarterly earnings data on Thursday, November, 5th. The company reported $0.58 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.58. The company had revenue of $4 billion for the quarter, compared to the consensus estimate of $4.09 billion. Teva Pharmaceutical Industries had a negative net margin of 24.17% and a positive trailing twelve-month return on equity of 19.32%. The company’s revenue was down 6.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.58 EPS.
View Teva Pharmaceutical Industries’ earnings history.
Teva Pharmaceutical Industries’ stock was trading at $9.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TEVA stock has increased by 39.2% and is now trading at $12.54.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:TEVA stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
17 analysts have issued 1-year price objectives for Teva Pharmaceutical Industries’ stock. Their forecasts range from $8.00 to $16.00. On average, they anticipate Teva Pharmaceutical Industries’ stock price to reach $12.29 in the next year. This suggests that the stock has a possible downside of 2.0%.
View analysts’ price targets for Teva Pharmaceutical Industries or view top-rated stocks among Wall Street analysts.
Teva Pharmaceutical Industries’ management team includes the following people:
Mr. Kare Schultz, Pres, CEO & Director (Age 60, Pay $5.6M)
Mr. Eliyahu Sharon Kalif, Exec. VP & CFO (Age 48, Pay $655.76k)
Dr. Hafrun Fridriksdottir, Exec. VP of Global R&D (Age 59, Pay $2.48M)
Mr. Brendan P. O’Grady, Exec. VP of North America Commercial (Age 54, Pay $1.56M)
Mr. Gianfranco Nazzi, Exec. VP of International Markets Commercial (Age 52, Pay $2.15M)
Mr. Eric Drapé, Exec. VP of Global Operations (Age 59)
Deborah A. Griffin, Sr. VP & Chief Accounting Officer
Mr. Kevin C. Mannix, Sr. VP of Investor Relations
Mr. David M. Stark, Exec. VP & Chief Legal Officer (Age 52)
Ms. Lori Queisser, Sr. VP & Global Compliance Officer
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
158 employees have rated Teva Pharmaceutical Industries CEO Kåre Schultz on Glassdoor.com. Kåre Schultz has an approval rating of 90% among Teva Pharmaceutical Industries’ employees.
Some companies that are related to Teva Pharmaceutical Industries include Regeneron Pharmaceuticals (REGN), BeiGene (BGNE), Alexion Pharmaceuticals (ALXN), Astellas Pharma (ALPMY), Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), MERCK Kommanditgesellschaft auf Aktien (MKGAF), CureVac (CVAC), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Horizon Therapeutics Public (HZNP) and Royalty Pharma (RPRX).
View all of TEVA’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Teva Pharmaceutical Industries investors own include General Electric (GE), AT&T (T), NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), Bank of America (BAC), Micron Technology (MU), Gilead Sciences (GILD), Johnson & Johnson (JNJ) and Cisco Systems (CSCO).
Teva Pharmaceutical Industries trades on the New York Stock Exchange (NYSE) under the ticker symbol “TEVA.”
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
Teva Pharmaceutical Industries’ stock is owned by many different retail and institutional investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.85%), Swiss National Bank (0.39%), Sumitomo Mitsui Trust Holdings Inc. (0.29%), SG Americas Securities LLC (0.11%), Private Management Group Inc. (0.10%) and HealthInvest Partners AB (0.08%). Company insiders that own Teva Pharmaceutical Industries stock include Brendan P O’grady, David Matthew Stark, Deborah A Griffin, Eric Drape, Hafrun Fridriksdottir, Luzich Partners Llc, Mark Sabag, Michael James Mcclellan, Notaristefani Carlo De, Richard Daniell, Rosemary A Crane, Sol J Barer and Sven Dethlefs.
View institutional ownership trends for Teva Pharmaceutical Industries.
TEVA stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Aperio Group LLC, Swiss National Bank, State of Wisconsin Investment Board, Daiwa Securities Group Inc., NuWave Investment Management LLC, Usca Ria LLC, and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. Company insiders that have sold Teva Pharmaceutical Industries company stock in the last year include Brendan P O’grady, David Matthew Stark, Deborah A Griffin, Eric Drape, Mark Sabag, Richard Daniell, and Rosemary A Crane.
View insider buying and selling activity for Teva Pharmaceutical Industries or view top insider-selling stocks.
TEVA stock was bought by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., HealthInvest Partners AB, SG Americas Securities LLC, Janney Montgomery Scott LLC, Private Management Group Inc., SkyOak Wealth LLC, XTX Markets LLC, and DNB Asset Management AS.
View insider buying and selling activity for Teva Pharmaceutical Industries or or view top insider-buying stocks.
Shares of TEVA can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of TEVA stock can currently be purchased for approximately $12.54.
Teva Pharmaceutical Industries has a market capitalization of $13.70 billion and generates $16.89 billion in revenue each year. The company earns $-998,000,000.00 in net income (profit) each year or $2.31 on an earnings per share basis.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How to buy Teva Pharmaceutical Industries Limited stock?
The safest and easiest way to buy FRA:TEV stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Abrir uma conta com um desses corretores é uma atitude inteligente, eles estão ativos há mais de dez anos, são muito seguros de usar e têm a melhor plataforma para comerciantes novatos e experientes. Se o senhor quiser saber mais, sugerimos-lhe que leia nossa carta de eToro ou DeGiro guias.
Where to buy Teva Pharmaceutical Industries stock?
You will first want to find a licensed broker that supports Teva Pharmaceutical Industries stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:TEVA stocks in a safe and complete environment.
Is NYSE:TEVA stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:TEVA stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Teva Pharmaceutical Industries stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:TEVA is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Teva Pharmaceutical Industries stock.
How do you trade Teva Pharmaceutical Industries stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Teva Pharmaceutical Industries stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:TEVA stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Teva Pharmaceutical Industries stock?
To sell your NYSE:TEVA stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Teva Pharmaceutical Industries stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:TEVA stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Bolsa de Valores de Paris (EPA)
Todas as ações da EPA Mais informações Ações da EPA O que é a Bolsa de Valores de Paris (EPA)? Agora
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
